An Open Label Dose Finding Safety and Efficacy in Children and Infants Infected With Schistosomiasis (S.Mansoni)
Clinical trial NCT02806232 · COMPLETED
Trial details
- NCT number
- NCT02806232
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-12
- Primary completion
- 2018-10-30
- Enrollment
- 444
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.